Stemtech (STEK) Income from Non-Controlling Interests (2021 - 2025)

Stemtech's (STEK) quarterly Income from Non-Controlling Interests came in at -$3135.0 in Q3 2025, down 238.92% year-on-year from $2256.7 in Q3 2024, and little changed quarter-over-quarter from -$3135.0 in Q2 2025.

Stemtech (STEK) Income from Non-Controlling Interests (2021 - 2025) Analysis & Trends

Stemtech has disclosed Income from Non-Controlling Interests across 5 years of filings, most recently posting -$3135.0 for Q3 2025.

  • Income from Non-Controlling Interests for Q3 2025 came in at -$3135.0, down 238.92% year-over-year; the trailing twelve-month figure through Dec 2025 was -$9405.0 (down 200.0% YoY), and the FY2025 annual result was -$3135.0, changed 0.0% from the prior year.
  • Income from Non-Controlling Interests came in at -$3135.0 for Q3 2025 at Stemtech, roughly flat from -$3135.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $1707.0 in Q3 2023 to a low of -$30707.0 in Q3 2022.
  • The 5-year median for Income from Non-Controlling Interests is -$3566.0 (2023), against an average of -$7545.8.
  • Across the five-year window, Income from Non-Controlling Interests surged 105.56% in 2023 and slumped 4643.48% in 2025, its largest moves.
  • Stemtech's Income from Non-Controlling Interests stood at -$8649.0 in 2021, then sank by 164.44% to -$22871.0 in 2022, then surged by 103.5% to $800.0 in 2023, then sank by 215.62% to -$925.0 in 2024, then tumbled by 238.92% to -$3135.0 in 2025.
  • The last three Income from Non-Controlling Interests figures came in at -$3135.0 (Q3 2025), -$3135.0 (Q2 2025), and -$3135.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 22.56 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Stemtech - - 354,677.00 -

Historic Data

Download Data
DateValue
Sep 30, 2025 -3,135.00
Jun 30, 2025 -3,135.00
Mar 31, 2025 -3,135.00
Sep 30, 2024 -925.00
Jun 30, 2024 69.00
Mar 31, 2024 -2,279.00
Dec 31, 2023 800.00
Sep 30, 2023 1,707.00
Jun 30, 2023 -3,997.00
Mar 31, 2023 -244.00
Dec 31, 2022 -22,871.00
Sep 30, 2022 -30,707.00
Jun 30, 2022 -19,665.00
Mar 31, 2022 -14,662.00
Dec 31, 2021 -8,649.00
Sep 30, 2021 -10,262.00
Jun 30, 2021 -10,658.00
Mar 31, 2021 -4,077.00